International – Mpox : l’OMS approuve un second vaccin, fabriqué par une société pharmaceutique...
Un nouveau vaccin contre la mpox, fabriqué par la société pharmaceutique japonaise KM Biologics pour un usage d’urgence, a été approuvé, mardi 19 novembre, par...
UK – Sparsentan approved to treat adult patients with primary immunoglobulin A nephropathy (IgAN)
IgA neuropathy, also known as Berger’s disease, is a kidney disease that occurs when an antibody called immunoglobulin A (IgA) builds up in your...
Europe – Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...
Eight new medicines recommended for approval
EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its November 2024 meeting.
The committee recommended granting a conditional...
Europe – Leqembi recommended for treatment of early Alzheimer’s disease
After re-examining its initial opinion, EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation to Leqembi (lecanemab) for treating mild cognitive impairment...
USA – FDA proposes removing oral phenylephrine from use in nasal decongestants
The US Food and Drug Administration (FDA) announced on Thursday plans to remove oral phenylephrine from the over-the-counter (OTC) monograph for nasal decongestants following...
UK – NHS rolls out ‘stop-smoking’ pill to help tens of thousands quit
Varenicline has been shown to work as well as vapes to help people stop smoking and be a more effective aid than nicotine-replacement gum...
UK – NICE recommends Blueprint Medicines’ Ayvakyt to treat rare blood disorder
The drug can now be used as a monotherapy to treat patients in England and Wales with the three subtypes of advanced SM: aggressive...
UK – NICE recommends remote monitoring technology for heart failure patients
The National Institute for Health and Care Excellence (NICE) has announced that people with heart failure can now stay healthier remotely through advanced remote...
France – Mettre à disposition les informations et données autour du médicament aux patients...
Chaque année en France, environ 130 000 personnes sont hospitalisées suite à des effets indésirables suspectés d’être dus à un mauvais usage des médicaments,...
UK – Pfizer’s Elrexfio recommended by NICE to treat relapsed and refractory multiple myeloma
The BCMA-directed bispecific antibody will now be available for use on the NHS in England via the Cancer Drugs Fund (CDF) while more evidence...
